4 yn gyfan gwbl o bell, swyddi yn UK
Hyderus o ran Anabledd
Gweithio o bell
Lleoliad
- UK (4)
- Eastern England (2)
- London (1)
- South West England (1)
Dyddiad hysbysebu
Categori
Math o gytundeb
Oriau
- Llawn amser (2)
- Rhan amser (2)
Mewngofnodwch nawr i greu rhybudd e-bost a derbyn y swyddi diweddaraf ar gyfer y chwiliad hon yn syth i'ch e-bost
MewngofnodiRegulatory Affairs Labelling Manager contract
- 24 May 2024
- Hays Specialist Recruitment - Uxbridge, London, EC2V 6DB
- £40.0 to £55.0 per hour
- £40 - £55 outside IR35
- Yn gyfan gwbl o bell
- Cytundeb
- Llawn amser
Regulatory Affairs Labelling Manager Your new company This consultancy is looking to strengthen their Regulatory Labelling group by taking on an experienced Regulatory Affairs Labelling professional for a contract job. This job is outside IR35 and has scope ...
Key Account Manager
- 22 May 2024
- SRG - Chipping Campden, Gloucestershire, GL55 6LD
- £55,000 to £65,000.00 per year
- Yn gyfan gwbl o bell
- Parhaol
- Llawn amser
Key Account Manager - Food & Drink Industry Do you thrive on building high-value relationships that drive revenue growth? Are you a strategic thinker with experience in the food & drink sector? We are seeking a driven and results-oriented Key Account Manager ...
Fractional CSO/Advisor - mRNA biotech
- 15 May 2024
- Hays Specialist Recruitment - Cambridge / fully remote, Cambridgeshire, CB2 0AA
- £250 to £300 per hour
- £250-300 per hour
- Yn gyfan gwbl o bell
- Cytundeb
- Rhan amser
Your new company You will be joining a breakthrough VC backed biotech who have recently raised a multi-million pound Seed funding round.They are pioneering novel treatments in the field of cancer immunoprevention and are currently developing a lead mRNA ...
Fractional CTO/CSO - mRNA biotech
- 13 May 2024
- Hays Specialist Recruitment - Cambridge / fully remote, Cambridgeshire, CB2 0AA
- £260 to £300 per hour
- £250-300 per hour
- Yn gyfan gwbl o bell
- Cytundeb
- Rhan amser
Your new company You will be joining a breakthrough VC backed biotech who have recently raised a multi-million pound Seed funding round.They are pioneering novel treatments in the field of cancer immunoprevention and are currently developing a lead mRNA ...
- 1